Trial intelligence / Profile preview

Intravenous haloperidol for prevention and treatment of delirium in mechanically ventilated ICU patients

2009-017842-30Phase 2Completed

Sponsor
West Hertfordshire Teaching Hospitals NHS Trust
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in delirium comparing Intravenous haloperidol with Placebo (2 arms). Primary endpoint: Delirium/coma-free days at 14 days. Started Jul 2010; status: completed.

02

Drugs

haloperidol
03

Conditions

delirium

Beyond the preview

Go deeper on 2009-017842-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017842-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call